This is a StreetInsider.com Premium Only Page

Rigel Pharma (RIGL) – Hot FDA News

Dec 1, 2022 05:04 PM Rigel Pharma (RIGL) Announces U.S. FDA Approval of REZLIDHIA for Treatment of Adult Patients with R/R Acute Myeloid Leukemia with Susceptible IDH1 Mutation

Dec 1, 2022 04:33 PM FDA approves olutasidenib for relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation

Nov 1, 2022 04:01 PM

Jun 8, 2022 07:02 AM

Aug 13, 2021 07:33 AM

Apr 17, 2018 01:45 PM

Apr 3, 2018 07:01 AM

Oct 3, 2017 07:31 AM

Oct 20, 2016 07:02 AM

Oct 24, 2013 07:34 AM

Aug 26, 2013 07:30 AM